SCHEMBL6947710

SCHEMBL6947710

CCCc1nc(N2CCc3ccccc3CC2)c(C#N)c(=O)n1CC(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.38
ALDH1A1 P00352 8/20 0.38
HPGD P15428 7/20 0.38
MAPT P10636 6/20 0.38
GRM2 Q14416 2/20 0.38
HSD17B10 Q99714 4/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
HTT P42858 4/20 0.37
TP53 P04637 2/20 0.37
MAPK1 P28482 2/20 0.36
NPSR1 Q6W5P4 2/20 0.35
TSHR P16473 2/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
POLB P06746 2/20 0.34
RAB9A P51151 1/20 0.34
CNR1 P21554 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NOD2 Q9HC29 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950991 0.87 GRM2 (0.37) KDM4EALDH1A1HPGDMAPTGRM2
SCHEMBL6947600 0.85 GRM2 (0.40) KDM4EALDH1A1HPGDMAPTGRM2
SCHEMBL6947484 0.82 ALDH1A1 (0.42) KDM4EALDH1A1HPGDMAPTGRM2
SCHEMBL6955474 0.81 GRM2 (0.39) KDM4EALDH1A1HPGDMAPTGRM2
SCHEMBL6950978 0.79 GRM2 (0.38) KDM4EALDH1A1HPGDMAPTGRM2
SCHEMBL6945569 0.79 ALDH1A1 (0.37) KDM4EALDH1A1HPGDMAPTGRM2
SCHEMBL6952941 0.78 KDM4E (0.35) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL6949276 0.78 GRM2 (0.39) KDM4EALDH1A1HPGDMAPTGRM2
SCHEMBL6952837 0.77 GRM2 (0.43) KDM4EALDH1A1HPGDMAPTGRM2
SCHEMBL6952709 0.77 GRM2 (0.42) KDM4EALDH1A1HPGDMAPTGRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed